Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prednisone-neostigmine interactions at cholinergic junctions.

M D Noble, J H Peacock, J A Lacher

    Muscle & Nerve
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Experience with Abdominal Aortic Aneurysims.

    Bristol medico-chirurgical journal (1963)·2017
    Same author

    A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis.

    Gut·2008
    Same author

    Surfactant-immobilized fibronectin enhances bioactivity and regulates sensory neurite outgrowth.

    Journal of biomedical materials research·2001
    Same author

    DBS and diathermy interaction induces severe CNS damage.

    Neurology·2001
    Same author

    Increased collagen production in fibroblasts cultured from irradiated skin and effect of TGF beta(1)- clinical study.

    British journal of cancer·2000
    Same author

    Cellular transplants as sources for therapeutic agents.

    Advanced drug delivery reviews·2000
    Same journal

    Fat-Fraction Quantification Using Three-Point Dixon Technique in Duchenne Muscular Dystrophy and Its Correlation With Clinical Progression and Genotypic Characteristics: A Single Centre One-Year Prospective Study.

    Muscle & nerve·2026
    Same journal

    Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

    Muscle & nerve·2026
    Same journal

    Electrical Modalities in the Rehabilitation of Peripheral Nerve Injuries: State of the Literature and Current Clinical Applications.

    Muscle & nerve·2026
    Same journal

    Reply to "Sural/Radial Amplitude Ratio in Non-Length-Dependent Neuropathy (NLDN): A Call for More Standardized Methodology and Further Evaluation of Distal NLDN".

    Muscle & nerve·2026
    Same journal

    Late-Onset Myasthenia Gravis: An Increasingly Frequent Clinical Entity With Distinctive Challenges.

    Muscle & nerve·2026
    Same journal

    Clinical Characteristics and Treatment Management of Seronegative Myasthenia Gravis: A Systematic Review of the Literature.

    Muscle & nerve·2026
    See all related articles

    Corticosteroid (prednisone) did not alter alpha-bungarotoxin binding sites in rat diaphragms. However, anticholinesterase (neostigmine) treatment significantly reduced these binding sites after one week.

    Area of Science:

    • Neuromuscular Junction Pharmacology
    • Muscle Physiology
    • Drug Effects on Receptor Binding

    Background:

    • Alpha-bungarotoxin binding sites are crucial indicators of nicotinic acetylcholine receptors at the neuromuscular junction.
    • Corticosteroids and anticholinesterase agents are commonly used in treating neuromuscular disorders, but their direct impact on receptor density requires clarification.

    Purpose of the Study:

    • To investigate the effects of prednisone and neostigmine on alpha-bungarotoxin binding site density in rat diaphragms.
    • To determine if combined treatment alters these effects.

    Main Methods:

    • Male rats were treated with prednisone and/or neostigmine.
    • Alpha-bungarotoxin binding assays were performed on diaphragm muscle samples, specifically in endplate regions.

    Related Experiment Videos

  • Quantification of toxin binding site density was analyzed.

    • Main Results:

    • Prednisone treatment, alone or with neostigmine, did not significantly affect alpha-bungarotoxin binding site density.
    • Neostigmine treatment alone reduced specific alpha-bungarotoxin binding to less than half of control levels within one week.

    Conclusions:

    • Prednisone does not appear to modulate the number of nicotinic acetylcholine receptors at the rat diaphragm neuromuscular junction.
    • Chronic neostigmine treatment leads to a significant downregulation of these receptors.